Revisiting immune-based therapies for aggressive follicular cell-derived thyroid cancers. | Thyroid;23(5): 529-42, 2013 May. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

Virtual Health Library

United States - Mexico Border

Subject descriptor lookup Advanced Search

Revisiting immune-based therapies for aggressive follicular cell-derived thyroid cancers.

French, Jena D.

Affiliation

French JD; Department of Medicine, Division of Endocrinology, Metabolism, and Diabetes, University of Colorado , Aurora, CO 80045, USA. jena.french@ucdenver.edu

Thyroid ; 23(5): 529-42, 2013 May.

Article in En | MEDLINE | ID: mdl-23317509

Subject(s)

Adenocarcinoma, Follicular/therapy; Immunomodulation; Thyroid Neoplasms/therapy; Adaptive Immunity; Adenocarcinoma, Follicular/immunology; Adenocarcinoma, Follicular/secondary; Animals; Humans; Immunity, Cellular; Lymphatic Metastasis/immunology; Thyroid Neoplasms/immunology

Search on Google

Full text: 1 Database: MEDLINE Main subject: Thyroid Neoplasms / Adenocarcinoma, Follicular / Immunomodulation Type of study: Prognostic_studies Limits: Animals / Humans Language: En Year: 2013 Type: Article

Search on Google

Full text: 1 Database: MEDLINE Main subject: Thyroid Neoplasms / Adenocarcinoma, Follicular / Immunomodulation Type of study: Prognostic_studies Limits: Animals / Humans Language: En Year: 2013 Type: Article